Table 3.
The age-standardized incidence and mortality rates along with the ASR -based mortality-to-incidence ratio due to leukemia among females of selected countries (n = 56)
| Country | Incidence | Mortality | ASR-based MIR | ||||
|---|---|---|---|---|---|---|---|
| ASIR | Cum.Risk | ASMR | Cum.Risk | 2012 | 2020 | δMIR | |
| Argentina | 4.9 | 0.89 | 2.9 | 0.7 | 0.71 | 0.59 | 0.12 |
| Australia | 8.4 | 1.77 | 2.6 | 1.02 | 0.42 | 0.31 | 0.11 |
| Austria | 6.2 | 1.25 | 2.6 | 0.92 | 0.28 | 0.42 | -0.14 |
| Belarus | 6.7 | 1.02 | 3 | 0.76 | 0.62 | 0.45 | 0.17 |
| Belgium | 10.4 | 1.98 | 3.1 | 1.15 | 0.37 | 0.30 | 0.07 |
| Brazil | 4 | 0.81 | 2.7 | 0.68 | 0.66 | 0.67 | -0.01 |
| Bulgaria | 4.6 | 0.68 | 2.3 | 0.69 | 0.56 | 0.50 | 0.06 |
| Canada | 7.6 | 1.58 | 2.6 | 0.92 | 0.31 | 0.34 | -0.03 |
| Chile | 5.1 | 0.87 | 2.7 | 0.67 | 0.58 | 0.53 | 0.05 |
| Colombia | 5.4 | 0.94 | 3.5 | 0.76 | 0.63 | 0.65 | -0.02 |
| Costa Rica | 5.6 | 0.91 | 3 | 0.72 | 0.62 | 0.53 | 0.09 |
| Croatia | 5 | 1.19 | 3.4 | 1.08 | 0.39 | 0.68 | -0.29 |
| Cuba | 4.6 | 0.78 | 2.6 | 0.61 | 0.60 | 0.56 | 0.04 |
| Cyprus | 6.5 | 1.59 | 3.6 | 1.45 | 0.35 | 0.55 | -0.20 |
| Czechia | 5.6 | 1.28 | 2.7 | 0.91 | 0.44 | 0.48 | -0.04 |
| Denmark | 6.6 | 1.33 | 3.1 | 1.13 | 0.40 | 0.47 | -0.07 |
| Ecuador | 5.9 | 1.04 | 4.3 | 0.89 | 0.71 | 0.73 | -0.02 |
| Egypt | 5.1 | 0.87 | 3.9 | 0.87 | 0.75 | 0.76 | -0.01 |
| Estonia | 6.8 | 1.25 | 2.9 | 0.94 | 0.46 | 0.43 | 0.03 |
| Finland | 5.4 | 1.03 | 2 | 0.68 | 0.31 | 0.37 | -0.06 |
| France | 7 | 1.59 | 2.6 | 1.01 | 0.33 | 0.37 | -0.04 |
| Germany | 6.7 | 1.36 | 2.7 | 1.04 | 0.21 | 0.40 | -0.19 |
| Iceland | 4 | 0.81 | 1.7 | 0.63 | 0.26 | 0.42 | -0.16 |
| Ireland | 7.4 | 1.46 | 2.5 | 0.91 | 0.25 | 0.34 | -0.09 |
| Italy | 6.8 | 1.27 | 2.8 | 0.89 | 0.22 | 0.41 | 0.19 |
| Jamaica | 4.4 | 0.64 | 3.3 | 0.6 | 0.67 | 0.75 | -0.08 |
| Japan | 5.4 | 0.78 | 1.7 | 0.51 | 0.25 | 0.31 | -0.06 |
| Kuwait | 6.6 | 1.64 | 4.2 | 1.24 | 0.55 | 0.64 | -0.09 |
| Latvia | 6.9 | 1.4 | 3.4 | 1.08 | 0.57 | 0.49 | 0.08 |
| Lithuania | 8.7 | 1.76 | 2.9 | 1.08 | 0.60 | 0.33 | 0.27 |
| Luxembourg | 3.1 | 1.23 | 1.8 | 0.88 | 0.35 | 0.58 | -0.23 |
| Malaysia | 5.6 | 0.69 | 3.9 | 0.61 | 0.72 | 0.69 | 0.03 |
| Malta | 5 | 0.99 | 1.3 | 0.54 | 0.31 | 0.26 | 0.05 |
| Mauritius | 5.1 | 0.74 | 2.9 | 0.63 | 0.54 | 0.57 | -0.03 |
| Netherlands | 6.3 | 1.16 | 2.5 | 0.97 | 0.30 | 0.39 | -0.09 |
| New Zealand | 7.6 | 1.62 | 3.4 | 1.24 | 0.40 | 0.45 | -0.05 |
| Norway | 7.2 | 1.46 | 2.4 | 0.8 | 0.30 | 0.33 | -0.03 |
| Philippines | 5.1 | 0.86 | 3.7 | 0.71 | 0.63 | 0.72 | -0.09 |
| Poland | 5.7 | 1.25 | 3.1 | 0.97 | 0.52 | 0.54 | -0.02 |
| Portugal | 6.3 | 1.28 | 2.7 | 0.83 | 0.34 | 0.43 | -0.09 |
| Qatar | 3.5 | 0.37 | 2.4 | 0.3 | 0.47 | 0.68 | -0.21 |
| Russian Federation | 5.7 | 0.92 | 2.7 | 0.61 | 0.56 | 0.47 | 0.09 |
| Serbia | 6.6 | 1.1 | 3.3 | 0.81 | 0.64 | 0.50 | 0.14 |
| Singapore | 7.9 | 1.28 | 2.5 | 0.68 | 0.31 | 0.32 | -0.01 |
| Slovakia | 6.5 | 1.5 | 4.4 | 1.26 | 0.50 | 0.68 | -0.18 |
| Slovenia | 6 | 1.43 | 2.9 | 1.19 | 0.36 | 0.48 | -0.12 |
| South Africa | 2.9 | 0.73 | 2.2 | 0.63 | 0.75 | 0.76 | -0.01 |
| Spain | 5.6 | 1.07 | 2.2 | 0.77 | 0.25 | 0.39 | -0.14 |
| Sweden | 6.2 | 1.16 | 2.4 | 0.92 | 0.30 | 0.39 | -0.09 |
| Switzerland | 6 | 1.16 | 2.1 | 0.73 | 0.24 | 0.35 | -0.11 |
| Thailand | 4.9 | 0.76 | 3 | 0.58 | 0.60 | 0.61 | -0.01 |
| Trinidad and Tobago | 5.1 | 0.6 | 3.5 | 0.51 | 0.68 | 0.69 | -0.01 |
| Ukraine | 4.9 | 0.66 | 2.5 | 0.4 | 0.55 | 0.51 | 0.04 |
| United Kingdom | 7 | 1.51 | 2.2 | 0.85 | 0.33 | 0.31 | 0.02 |
| United States of America | 9 | 1.87 | 2.5 | 0.88 | 0.54 | 0.28 | 0.26 |
| Uruguay | 5.1 | 1.07 | 2.7 | 0.84 | 0.66 | 0.53 | 0.13 |
ASIR age-standardized incidence rate, Cum cumulative, ASMR age-standardized mortality rate, MIR mortality-to-incidence ratio